Rapid and highly multiplexed pathogen detection for sepsis patients with compressed sensing and digital PCR

Active Project Grant Awarded Last action

Award ID
R43CK000714
Recipient
Awarding agency
Obligated
$296,185

Award facts

Assistance listing
93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security
Completion date 8% complete
Funding agency
Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

About this award

The Centers for Disease Control and Prevention awarded Anvil Diagnostics Inc. $296,185 on September 30, 2026, under the Protecting and Improving Health Globally program (CFDA 93.318) to develop rapid and highly multiplexed pathogen detection for sepsis patients using compressed sensing and digital PCR.

Work is performed in Massachusetts. The period of performance runs from the award date through September 29, 2027. The assistance type is a Project Grant.

Quick answers

Who received award R43CK000714?

R43CK000714 was awarded to Anvil Diagnostics Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2026.

How much is award R43CK000714 worth?

$296,185 has been obligated on R43CK000714.

Which agency awarded R43CK000714?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43CK000714, with funding from Office of the Director (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award